{
  "id": 20202118,
  "title": "Teradyne director Marilyn Matz sells $270,264 in common stock",
  "url": "https://urgent.news/2026/11/15/teradyne-director-marilyn-matz-sells-270-264-in-common-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-15T16:46:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/teradyne-director-marilyn-matz-sells-270264-in-common-stock-93CH-5028018"
  },
  "original_language": "en",
  "account": null,
  "summary": "Director Marilyn Matz of Teradyne, Inc. sold 800 shares of the company’s common stock on September 15, 2026, for a total of $270,264, at a price of $337.83 per share. This sale, conducted under a Rule 10b5-1 trading plan adopted in February 2026, occurred as the stock price was 26% lower than its current level, marking a decline over the past six months. Despite this, Teradyne remains undervalued according to InvestingPro’s analysis and holds a strong financial health score with a perfect Piotroski Score of 9. Following the transaction, Matz holds 14,240.675 shares of Teradyne common stock. The article also highlights Teradyne’s strong financial performance in Q3 2026, with non-GAAP earnings surpassing expectations and significant revenue growth driven by AI-related demand. In addition, Jefferies initiated coverage on Teradyne with a buy rating and a price target of $284.00, anticipating increased market share due to growth in the automated test equipment sector.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}